|
|
||||||||




,

* Division of Respiratory Infections and
Division of Pulmonary Diseases, Department of Medicine, National Jewish Medical and Research Center, Denver, CO 80206;
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, CO 80262; and
Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
Pulmonary bacterial diseases are a leading cause of mortality in the U.S. Innate immune response is vital for bacterial clearance from the lung, and TLRs play a critical role in this process. Toll-IL-1R domain-containing adaptor protein (TIRAP) is a key molecule in the TLR4 and 2 signaling. Despite its potential importance, the role of TIRAP-mediated signaling in lung responses has not been examined. Our goals were to determine the role of TIRAP-dependent signaling in the induction of lung innate immune responses against Escherichia coli LPS and viable E. coli, and in lung defense against E. coli in mice. LPS-induced neutrophil sequestration; NF-
B translocation; keratinocyte cell-derived chemokine, MIP-2, TNF-
, and IL-6 expression; histopathology; and VCAM-1 and ICAM-1 expression were abolished in the lungs of TIRAP/ mice. A cell-permeable TIRAP blocking peptide attenuated LPS-induced lung responses. Furthermore, immune responses in the lungs of TIRAP/ mice were attenuated against E. coli compared with TIRAP+/+ mice. TIRAP/ mice also had early mortality, higher bacterial burden in the lungs, and more bacterial dissemination following E. coli inoculation. Moreover, we used human alveolar macrophages to examine the role of TIRAP signaling in the human system. The TIRAP blocking peptide abolished LPS-induced TNF-
, IL-6, and IL-8 expression in alveolar macrophages, whereas it attenuated E. coli-induced expression of these cytokines and chemokines. Taken together, this is the first study illustrating the crucial role of TIRAP in the generation of an effective early immune response against E. coli LPS and viable E. coli, and in lung defense against a bacterial pathogen.
This article has been cited by other articles:
![]() |
S. Kenzel, S. Santos-Sierra, S. D. Deshmukh, I. Moeller, B. Ergin, K. A. Fitzgerald, E. Lien, S. Akira, D. T. Golenbock, and P. Henneke Role of p38 and Early Growth Response Factor 1 in the Macrophage Response to Group B Streptococcus Infect. Immun., June 1, 2009; 77(6): 2474 - 2481. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cai, R. L. Zemans, S. K. Young, G. S. Worthen, and S. Jeyaseelan Myeloid Differentiation Protein-2-Dependent and -Independent Neutrophil Accumulation during Escherichia coli Pneumonia Am. J. Respir. Cell Mol. Biol., June 1, 2009; 40(6): 701 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Y. Mong and Q. Wang Activation of Rho Kinase Isoforms in Lung Endothelial Cells during Inflammation J. Immunol., February 15, 2009; 182(4): 2385 - 2394. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Craig, J. Mai, S. Cai, and S. Jeyaseelan Neutrophil Recruitment to the Lungs during Bacterial Pneumonia Infect. Immun., February 1, 2009; 77(2): 568 - 575. [Full Text] [PDF] |
||||
![]() |
R. Ghose, D. White, T. Guo, J. Vallejo, and S. J. Karpen Regulation of Hepatic Drug-Metabolizing Enzyme Genes by Toll-Like Receptor 4 Signaling Is Independent of Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein Drug Metab. Dispos., January 1, 2008; 36(1): 95 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jeyaseelan, S. K. Young, M. B. Fessler, Y. Liu, K. C. Malcolm, M. Yamamoto, S. Akira, and G. S. Worthen Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-beta (TRIF)-Mediated Signaling Contributes to Innate Immune Responses in the Lung during Escherichia coli Pneumonia J. Immunol., March 1, 2007; 178(5): 3153 - 3160. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Thorley, P. A. Ford, M. A. Giembycz, P. Goldstraw, A. Young, and T. D. Tetley Differential Regulation of Cytokine Release and Leukocyte Migration by Lipopolysaccharide-Stimulated Primary Human Lung Alveolar Type II Epithelial Cells and Macrophages J. Immunol., January 1, 2007; 178(1): 463 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jeyaseelan, S. K. Young, M. Yamamoto, P. G. Arndt, S. Akira, J. K. Kolls, and G. S. Worthen Toll/IL-1R Domain-Containing Adaptor Protein (TIRAP) Is a Critical Mediator of Antibacterial Defense in the Lung against Klebsiella pneumoniae but Not Pseudomonas aeruginosa J. Immunol., July 1, 2006; 177(1): 538 - 547. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |